In vitro susceptibilities of bacterial isolates from conjunctival flora to gatifloxacin, levofloxacin, tosufloxacin, and moxifloxacin

Eye and Contact Lens

Volumn 34, Issue 2, 2008, Pages 109-112

  Yamada, Masakazu ^a   Hatou, Shin ^a   Yoshida, Junko ^a  

^a NATIONAL HOSPITAL ORGANIZATION TOKYO MEDICAL CENTER   (Japan)

Author keywords

Bacterial flora; Conjunctiva; Drug resistance; Fluoroquinolone; Ocular infection

Indexed keywords

GATIFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; TOSUFLOXACIN;

ADOLESCENT; ADULT; AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONJUNCTIVA; CONTROLLED STUDY; EYE SURGERY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AZA COMPOUNDS; BACTERIA; CHILD; CONJUNCTIVA; DRUG RESISTANCE, MICROBIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NAPHTHYRIDINES; OFLOXACIN; QUINOLINES;

EID: 40449100816     PISSN: 15422321     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICL.0b013e31813c102a     Document Type: Article

References (16)

1. O'Brien TP. Bacterial keratitis. In: Krachmer JH, Mannis MJ, Holland EJ, eds. Cornea and External Disease: Clinical Diagnosis and Management, vol. II. St. Louis, Mosby-Year Book, 1997, pp 1139-1190.
2. Neu HC. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol 1991;112:S15-S24.
3. Leibowitz HM. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. Am J Ophthalmol 1991;112:S34-S47.
4. O'Brien TP, Maquire MG, Fink NE, et al. Efficacy of ofloxacin versus cefazolin and tobramycin in the therapy for bacterial keratitis: Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 1995;113:1257-1265.
5. Hyndiuk RA, Eiferman RA, Caldwell DR, et al. Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ophthalmology 1996;103:1854-62.
6. Chalita MG, Hüfling-Lima AN, Paranhos A, et al. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during period of 15 years. Am J Ophthalmol 2004;137:43-51.
7. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis. Ophthalmology 1999;106:1313-1318.
8. Kurokawa N, Hayashi K, Konishi M, et al. Increasing ofloxacin resistance of bacterial flora from conjunctival sac of preoperative ophthalmic patients in Japan. Jpn J Ophthalmol 2002;46:586-589.
9. Sakurai M, Hayashi K, Obazawa M, et al. Levofloxacin-resistant bacteria in conjunctival flora of patients undergoing intraocular surgery [in Japanese]. J Eye 2005;22:97-100.
10. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 2004;49:S79-S83.
11. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobacterial Susceptibility Testing: Sixteenth informational supplement. 2006;25:M100-S16.
12. Graves A, Henry M, O'Brien TP, et al. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones. Cornea 2001;20:301-305.
13. Stern GA. Contact lens associated bacterial keratitis: Past, present and future. CLAO J 1998;24:52-56.
14. Liesegang TJ. Use of antimicrobials to prevent postoperative infection in patients with cataract. Curr Opin Ophthalmol 2001;12:68-74.
15. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the endophthalmitis vitrectomy study. Am J Ophthalmol 1996;122:1-17.
16. Tungsiripat T, Sarayba MA, Kaufman MB, et al. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model. Am J Ophthalmol 2003;136:76-81.